PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
07-Apr-2025 European Commission approves Johnson & Johnson’s subcutaneous DARZALEX® (daratumumab)-based quadruplet regimen for the treatment of patients with newly diagnosed multiple myeloma, regardless of transplant eligibility Johnson & Johnson
07-Apr-2025 ADULT PATIENTS IN SCOTLAND WITH HEREDITARY TRANSTHYRETIN-MEDIATED AMYLOIDOSIS WITH STAGE 1 AND 2 POLYNEUROPATHY CAN NOW ACCESS ASTRAZENCA’S WAINZUA™▼(EPLONTERSEN) AstraZeneca
07-Apr-2025 Veranova Welcomes Dr. Scott Zugel as Global VP of Analytical Research Development Operations Veranova
07-Apr-2025 ADULT PATIENTS IN SCOTLAND WITH HEREDITARY TRANSTHYRETIN-MEDIATED AMYLOIDOSIS WITH STAGE 1 AND 2 POLYNEUROPATHY CAN NOW ACCESS ASTRAZENCA’S WAINZUA™▼(EPLONTERSEN) AstraZeneca
07-Apr-2025 CureVac Receives U.S. FDA IND Clearance to Initiate Phase 1 Clinical Trial for Novel mRNA-Based Precision Immunotherapy in Squamous Non-Small Cell Lung Cancer CureVac
07-Apr-2025 Veranova Welcomes Dr. Scott Zugel as Global VP of Analytical Research Development Operations Veranova
07-Apr-2025 Registration now open for Advanced Therapies Europe 2025 – where innovation meets opportunity Phacilitate
07-Apr-2025 Nordic Pharma Announces CE Mark Approval for Lacrifill® Canalicular Gel, Paving the Way for European Launch Nordic Group B.V.
07-Apr-2025 Angelini Ventures Appoints Seasoned Life Sciences Investor, Dr. Regina Hodits, as Managing Director Angelini Ventures
04-Apr-2025 The government and ABPI agree to accelerate a planned review of VPAG ABPI
04-Apr-2025 ABPI response to DSIT spending allocations ABPI
04-Apr-2025 OncoZenge Strengthens Phase 3 Sponsor Team for Regulatory Affairs OncoZenge
04-Apr-2025 Lundbeck to present positive pipeline data at American Academy of Neurology (AAN) Annual Meeting Lundbeck
03-Apr-2025 Honeywell Unveils AI-Assisted Automation Platform To Transform Life Sciences Manufacturing Industry Honeywell
03-Apr-2025 AVEROA Receives Positive Opinion from the European Medicines Agency for XOANACYL®, an Oral Therapy for Chronic Kidney Disease (CKD) AVEROA
03-Apr-2025 CSL Behring and GKV-Spitzenverband Agree on Reimbursement Price for HEMGENIX® – Europe's First Gene Therapy for Haemophilia B CSL Behring
03-Apr-2025 Hansa Biopharma to host Q1 2025 interim results conference call Hansa Biopharma
03-Apr-2025 AlzeCure Pharma publishes its Annual Report for 2024 AlzeCure Pharma
03-Apr-2025 Phesi launches self-service Investigator Site Profiler solution to enhance precision of investigator site selection Phesi
03-Apr-2025 OncoZenge presents BupiZenge™ Phase 3 abstract at leading supportive cancer care conference in the US in June OncoZenge